Management of end-stage liver disease in chronic hepatitis B

Hui Hui Tan, Paul Martin

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The consequences of chronic hepatitis B virus infection include hepatocellular carcinoma and liver cirrhosis. Effective antiviral therapy in patients with hepatitis B with advanced liver disease with viral suppression and sustained HBeAg seroconversion (where applicable) may abort hepatic decompensation, diminish hepatocellular risk, and reduce the risk of viral recurrence after transplantation. Overt hepatic decompensation is an indication for referral to a transplant center.

Original languageEnglish
Pages (from-to)477-493
Number of pages17
JournalClinics in Liver Disease
Volume14
Issue number3
DOIs
StatePublished - Aug 1 2010

Fingerprint

End Stage Liver Disease
Chronic Hepatitis B
Hepatitis B e Antigens
Liver
Virus Diseases
Hepatitis B
Hepatitis B virus
Liver Cirrhosis
Antiviral Agents
Liver Diseases
Hepatocellular Carcinoma
Referral and Consultation
Transplantation
Transplants
Recurrence
Therapeutics
Sustained Virologic Response
Seroconversion

Keywords

  • Antiviral therapy
  • Cirrhosis
  • End-stage liver disease
  • Hepatitis B
  • Liver transplantation

ASJC Scopus subject areas

  • Hepatology

Cite this

Management of end-stage liver disease in chronic hepatitis B. / Tan, Hui Hui; Martin, Paul.

In: Clinics in Liver Disease, Vol. 14, No. 3, 01.08.2010, p. 477-493.

Research output: Contribution to journalArticle

@article{3a16b4c439724e319c25610d8b3e0880,
title = "Management of end-stage liver disease in chronic hepatitis B",
abstract = "The consequences of chronic hepatitis B virus infection include hepatocellular carcinoma and liver cirrhosis. Effective antiviral therapy in patients with hepatitis B with advanced liver disease with viral suppression and sustained HBeAg seroconversion (where applicable) may abort hepatic decompensation, diminish hepatocellular risk, and reduce the risk of viral recurrence after transplantation. Overt hepatic decompensation is an indication for referral to a transplant center.",
keywords = "Antiviral therapy, Cirrhosis, End-stage liver disease, Hepatitis B, Liver transplantation",
author = "Tan, {Hui Hui} and Paul Martin",
year = "2010",
month = "8",
day = "1",
doi = "10.1016/j.cld.2010.05.006",
language = "English",
volume = "14",
pages = "477--493",
journal = "Clinics in Liver Disease",
issn = "1089-3261",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Management of end-stage liver disease in chronic hepatitis B

AU - Tan, Hui Hui

AU - Martin, Paul

PY - 2010/8/1

Y1 - 2010/8/1

N2 - The consequences of chronic hepatitis B virus infection include hepatocellular carcinoma and liver cirrhosis. Effective antiviral therapy in patients with hepatitis B with advanced liver disease with viral suppression and sustained HBeAg seroconversion (where applicable) may abort hepatic decompensation, diminish hepatocellular risk, and reduce the risk of viral recurrence after transplantation. Overt hepatic decompensation is an indication for referral to a transplant center.

AB - The consequences of chronic hepatitis B virus infection include hepatocellular carcinoma and liver cirrhosis. Effective antiviral therapy in patients with hepatitis B with advanced liver disease with viral suppression and sustained HBeAg seroconversion (where applicable) may abort hepatic decompensation, diminish hepatocellular risk, and reduce the risk of viral recurrence after transplantation. Overt hepatic decompensation is an indication for referral to a transplant center.

KW - Antiviral therapy

KW - Cirrhosis

KW - End-stage liver disease

KW - Hepatitis B

KW - Liver transplantation

UR - http://www.scopus.com/inward/record.url?scp=77954632240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954632240&partnerID=8YFLogxK

U2 - 10.1016/j.cld.2010.05.006

DO - 10.1016/j.cld.2010.05.006

M3 - Article

C2 - 20638026

AN - SCOPUS:77954632240

VL - 14

SP - 477

EP - 493

JO - Clinics in Liver Disease

JF - Clinics in Liver Disease

SN - 1089-3261

IS - 3

ER -